rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Park Ha Biological Technology Co., Ltd. - Class A

BYAH · Nasdaq

MaterialsChemicalsNot moving yet

BYAH stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 63.7% below that average now. Chemicals: 25% of its 85 stocks in an uptrend (−1 points in four weeks); Materials: 18% (−6 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
25% -1 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
2 (+0)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

20 Apr – 19 Oct
18%38%58%Apr 26Jun 26Jul 26Sep 26Oct 26

Chemicals: A minority of its stocks are in an uptrend and the share has held steady. Materials: Few of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders2+0 on the quarter
New · exited1 · 1
Reported value$25K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
MORGAN STANLEYadded · filed 13 Aug 202625,016$25K+25,000+156250.0%
Caitong International Asset Management Co., Ltdnew · filed 5 Aug 20263$3+3
31 Dec 2024 – 30 Jun 2026
2813Dec 24Jun 25Sep 25Mar 26Jun 26

News

No headline names it lately.

Everyone who traded it

Xiaoyan Zhu Company insiderCFO · last 3 Aug 20260 · 0

Same industry

FF FutureFuelLeading+19%
IOSP InnospecLeading+16%
MEOH MethanexLeading+11%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Oct 202594.4%
Operating profit marginFY 2025 · to 31 Oct 2025-956%
Free cash flow marginFY 2025 · to 31 Oct 2025-0.1%
Return on capital employedFY 2024 · to 31 Oct 202450.9%
Cash conversionFY 2024 · to 31 Oct 2024201%
Research spendFY 2025 · to 31 Oct 20259.4%
Revenue growthFY 2025 · to 31 Oct 20256.0%
Share count trendFY 2025 · to 31 Oct 2025-97.6%
Cash and equivalentsFY 2025 · to 31 Oct 2025$3.8M
Free cash flowFY 2025 · to 31 Oct 2025−$2,973

Analyst forecasts

No analyst forecasts yet.